NLRP3 Inflammasome Architecture and Components
The NLRP3 inflammasome is a supramolecular complex consisting of: (1) NLRP3 protein (nucleotide- binding oligomerization domain, leucine-rich repeat, and pyrin domain-containing protein 3; encoded by NLRP3/NACHT-LRR-PYD gene), containing a pyrin domain (PYD) for protein-protein interactions, a central NACHT (nucleotide-binding and oligomerization) domain, and C-terminal leucine-rich repeats (LRRs); (2) ASC adaptor protein (apoptosis-associated speck-like protein containing a CARD; ASC/PYCARD), which bridges NLRP3-PYD to pro-caspase-1; (3) pro-caspase-1 (CASP1, two-chain inactive pro-form with pro-domain, p20 catalytic, p10 catalytic); and optionally (4) pro-caspase-4/5 (CASP4/CASP5, non-canonical inflammasome sensors of intracellular LPS). Macrophages and neutrophils express the highest levels, with secondary expression in dendritic cells, lymphocytes, and fibroblasts.
Signal 1: Priming and NF-kappaB-Dependent Transcription
Signal 1 (priming) requires NF-kappaB-dependent transcription of NLRP3, pro-IL-1beta, and pro-IL-18 genes. TLR4 ligation by LPS (via CD14/MD-2/TLR4-TRAF6-TAK1-IKK/MAPK pathways) activates NF-kappaB, driving RELA/p65-p50 heterodimer binding to kappaB elements in the NLRP3, IL1B, and IL18 promoters. Signal 1 also increases intracellular ATP and UDP-glucose pools (glycolytic and biosynthetic fuel for inflammasome assembly and egress). Spirulina NF- kappaB inhibition (via IkappaBalpha stabilisation by PCB-Nrf2-antioxidant suppression of NADPH oxidase) directly suppresses the priming step, reducing baseline NLRP3/pro-IL-1beta abundance. Additionally, Nrf2-driven GCLC-glutathione synthesis opposes ROS-driven IKK activation during the priming phase.
Signal 2: Activation Pathways - K+ Efflux, ROS, and Cathepsin B
Signal 2 (activation) involves multiple converging danger signals: (1) K+ efflux: NLRP3 senses a fall in intracellular K+ concentration, with a threshold around 50-70 millimolar (resting ~140 mM). K+ efflux is triggered by ATP binding P2X7 receptors (heptameric ion channels), osmotic stress, or pore-forming toxins. The intracellular K+ sensor for NLRP3 remains debated; candidates include Nedd4-like ubiquitin ligase acting on K+ channels, or direct NLRP3-LRR K+ sensing. (2) ROS: mitochondrial (Complex I/III) and cytoplasmic (NOX1/2/4) superoxide/H2O2 prime NLRP3, possibly via lipid peroxidation products and electrophilic modification of NLRP3 Cys residues. (3) Lysosomal cathepsin B release: particulate agonists (monosodium urate MSU, calcium pyrophosphate CPP, silica) are phagocytosed; phagolysosomal acidification and reactive lipid/ROS stress trigger lysosomal rupture and cathepsin B (CTSB) release into the cytoplasm, which promotes NLRP3-ASC-pro-caspase-1 assembly. Spirulina reduces all three pathways: AMPK inhibits P2X7/ATP-driven K+ efflux; Nrf2-HO-1-CO and GCLC suppress mitochondrial/NOX ROS; and AMPK-mTORC1 inhibition reduces lysosomal acidification and autophagy-mediated lysosomal rupture.
NLRP3 Inflammasome Assembly: PYD-PYD Polymerisation and ASC Speck Formation
Upon Signal 2, the NLRP3 PYD binds the ASC PYD in a template-directed manner, nucleating PYD-PYD polymerisation into a fibrous scaffold. ASC serves as a bridge: its PYD binds NLRP3, while its CARD recruits and nucleates pro-caspase-1 CARD-CARD polymerisation. This creates a macromolecular supracomplex, visible as a visible "ASC speck" of 0.5-2 microns diameter in confocal microscopy. The PYD polymerisation follows a nucleation-elongation mechanism: the initial NLRP3-ASC nucleation is rate-limiting; once nucleated, PYD filaments elongate by strand exchange of incoming PYD molecules. Spirulina-Nrf2-induced HO-1-CO and itaconate analogy (via PCB-Keap1 Cys288) both inhibit NLRP3 PYD oligomerisation and ASC speck nucleation, preventing inflammasome assembly even in the presence of K+ efflux and ROS signals.
Pro-Caspase-1 Autoprocessing and IL-1beta/IL-18 Maturation
Pro-caspase-1 molecules are brought into close proximity by CARD-CARD polymerisation on the ASC platform. This proximity enables transproteolytic autoprocessing: each pro-caspase-1 cleaves adjacent pro-caspase-1 molecules to generate active p20/p10 heterodimeric caspase-1, which catalyses peptide bond cleavage after Asp residues. The primary substrates are pro-IL-1beta (Asp117 cleavage→mature IL-1beta) and pro-IL-18 (Asp35 cleavage→mature IL-18). Both mature IL-1beta and IL-18 are secreted via non-classical routes (TSPAN2, secretory autophagy, direct membrane rupture), not ER-Golgi pathway. Caspase-1 also cleaves GSDMD (gasdermin D), generating an N-terminal fragment (GSDMD-N) that oligomerises to form pyroptotic pores.
Gasdermin D (GSDMD) and Pyroptotic Pore Formation
GSDMD is a pore-forming protein with an N-terminal executioner domain (1-275 aa) and a C- terminal inhibitory domain (276-655 aa). Pro-caspase-1-mediated cleavage at Asp276 releases the N-terminal fragment (GSDMD-N), which oligomerises as a 8-9-meric pore in the plasma membrane and mitochondrial outer membrane. GSDMD-N pores are ~2-3 nm diameter and permeable to ions and small molecules, causing plasma membrane depolarisation, cell swelling, and osmotic lysis. GSDMD-N also translocates to the nucleus and has poorly understood roles in chromatin remodelling and cell fate decisions. Canonical pyroptosis (GSDMD-N-mediated) is considered immunologically important because cell rupture releases mature IL-1beta/IL-18 and danger- associated molecular patterns (DAMPs) like ATP, LDH, and HMGB1, attracting and activating bystander immune cells. Spirulina AMPK-mTORC1 inhibition may suppress GSDMD pore formation by reducing mitochondrial permeability transition that amplifies pore conductance.
Non-Canonical NLRP3: CASP4/5 and Gasdermin E
Non-canonical inflammasome activation occurs when intracellular LPS (from Gram-negative bacteria or transfection) is sensed by pro-caspase-4 (CASP4, human ortholog CASP11 in mice) and pro-caspase-5 (CASP5). These are directly activated by LPS-lipid A via CARD-LPS interaction without NLRP3, ASC, or Signal 1 priming. CASP4/5 cleave gasdermin E (GSDME, not GSDMD), which forms similar oligomeric pores. Non-canonical inflammasome activation also triggers mtROS and subsequent NLRP3 activation (crosstalk), amplifying pyroptotic responses. Spirulina LPS-binding capacity (via spirulan heteropolysaccharide and polysaccharide components) may sequester circulating LPS, reducing intracellular LPS bioavailability and CASP4/5 activation.
Related Reading
Summary
NLRP3 inflammasome activation is a multi-signal, multi-step process: Signal 1 (NF-kappaB-driven NLRP3/pro-IL-1beta transcription) + Signal 2 (K+ efflux, ROS, cathepsin B) triggers PYD-PYD polymerisation, ASC speck nucleation, pro-caspase-1 autoprocessing, GSDMD-N pore formation, and pyroptotic IL-1beta/IL-18 release. Spirulina interrupts this cascade at every level: NF-kappaB suppression (priming), AMPK-antioxidant suppression of K+ efflux and ROS (Signal 2), PCB-Keap1-Nrf2 inhibition of NLRP3 PYD assembly, and possibly mitochondrial membrane stabilisation. The resulting shift away from pyroptosis toward necroptosis/apoptosis and resolution programmes is therapeutically valuable in sepsis, IBD, gout, and neurodegenerative disease.